BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2692557)

  • 1. Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli.
    Danley DE; Geoghegan KF; Scheld KG; Lee SE; Merson JR; Hawrylik SJ; Rickett GA; Ammirati MJ; Hobart PM
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1043-50. PubMed ID: 2692557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.
    Strickler JE; Gorniak J; Dayton B; Meek T; Moore M; Magaard V; Malinowski J; Debouck C
    Proteins; 1989; 6(2):139-54. PubMed ID: 2695927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies.
    Cheng YS; McGowan MH; Kettner CA; Schloss JV; Erickson-Viitanen S; Yin FH
    Gene; 1990 Mar; 87(2):243-8. PubMed ID: 2158928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of self-processed HIV-1 protease in Escherichia coli using a synthetic gene.
    Hostomsky Z; Appelt K; Ogden RC
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1056-63. PubMed ID: 2662971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
    Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
    J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity purification of the HIV-1 protease.
    Heimbach JC; Garsky VM; Michelson SR; Dixon RA; Sigal IS; Darke PL
    Biochem Biophys Res Commun; 1989 Nov; 164(3):955-60. PubMed ID: 2686642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete mutagenesis of the HIV-1 protease.
    Loeb DD; Swanstrom R; Everitt L; Manchester M; Stamper SE; Hutchison CA
    Nature; 1989 Aug; 340(6232):397-400. PubMed ID: 2666861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.
    Rittenhouse J; Turon MC; Helfrich RJ; Albrecht KS; Weigl D; Simmer RL; Mordini F; Erickson J; Kohlbrenner WE
    Biochem Biophys Res Commun; 1990 Aug; 171(1):60-6. PubMed ID: 2203350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cloning and expression in Escherichia coli of the pol region of human immunodeficiency virus genome].
    Shulenin SV; Tsareva NV; Sitnikova IuB; Bobkov AF; Garaev MM
    Dokl Akad Nauk SSSR; 1990; 310(1):210-3. PubMed ID: 1692526
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification, characterization and crystallization of recombinant HIV-1 reverse transcriptase.
    Bhikhabhai R; Joelson T; Unge T; Strandberg B; Carlsson T; Lövgren S
    J Chromatogr; 1992 Jun; 604(1):157-70. PubMed ID: 1379251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level production of active HIV-1 protease in Escherichia coli.
    Rangwala SH; Finn RF; Smith CE; Berberich SA; Salsgiver WJ; Stallings WC; Glover GI; Olins PO
    Gene; 1992 Dec; 122(2):263-9. PubMed ID: 1487142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies.
    Nguyen HL; Nguyen TT; Vu QT; Le HT; Pham Y; Trinh PL; Bui TP; Phan TN
    Protein Expr Purif; 2015 Dec; 116():59-65. PubMed ID: 26231073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
    Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
    Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The properties of HIV protease synthesized in E. coli cells].
    Shulenin SV; Tarasova NI; Gul'nik SV; Bobkov AF; Bogdanov AA; Stepanov VM; Garaev MM
    Vopr Virusol; 1990; 35(3):206-9. PubMed ID: 2219853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An E. coli expression system which detoxifies the HIV protease.
    Korant BD; Rizzo CJ
    Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 protease: mutagenesis of asparagine 88 indicates a domain required for dimer formation.
    Guenet C; Leppik RA; Pelton JT; Moelling K; Lovenberg W; Harris BA
    Eur J Pharmacol; 1989 Dec; 172(6):443-51. PubMed ID: 2693124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography.
    Wondrak EM; Louis JM; Mora PT; Oroszlan S
    FEBS Lett; 1991 Mar; 280(2):347-50. PubMed ID: 2013336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, expression and purification of a recombinant poly-histidine-linked HIV-1 protease.
    Leuthardt A; Roesel JL
    FEBS Lett; 1993 Jul; 326(1-3):275-80. PubMed ID: 8325379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.
    Darke PL; Leu CT; Davis LJ; Heimbach JC; Diehl RE; Hill WS; Dixon RA; Sigal IS
    J Biol Chem; 1989 Feb; 264(4):2307-12. PubMed ID: 2644259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.